7-92528840-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_032120.4(RBM48):c.27G>A(p.Gly9Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0133 in 1,614,042 control chromosomes in the GnomAD database, including 183 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.010 ( 11 hom., cov: 32)
Exomes 𝑓: 0.014 ( 172 hom. )
Consequence
RBM48
NM_032120.4 synonymous
NM_032120.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.908
Genes affected
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 7-92528840-G-A is Benign according to our data. Variant chr7-92528840-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 1211594.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.908 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0101 (1541/152312) while in subpopulation NFE AF= 0.0162 (1101/68024). AF 95% confidence interval is 0.0154. There are 11 homozygotes in gnomad4. There are 677 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 11 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RBM48 | NM_032120.4 | c.27G>A | p.Gly9Gly | synonymous_variant | 1/5 | ENST00000265732.10 | NP_115496.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RBM48 | ENST00000265732.10 | c.27G>A | p.Gly9Gly | synonymous_variant | 1/5 | 1 | NM_032120.4 | ENSP00000265732.5 | ||
RBM48 | ENST00000481551.5 | c.27G>A | p.Gly9Gly | synonymous_variant | 1/4 | 1 | ENSP00000419242.1 | |||
RBM48 | ENST00000496410 | c.-407G>A | 5_prime_UTR_variant | 1/3 | 3 | ENSP00000418333.1 |
Frequencies
GnomAD3 genomes AF: 0.0101 AC: 1540AN: 152192Hom.: 11 Cov.: 32
GnomAD3 genomes
AF:
AC:
1540
AN:
152192
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0106 AC: 2626AN: 248856Hom.: 15 AF XY: 0.0105 AC XY: 1423AN XY: 135200
GnomAD3 exomes
AF:
AC:
2626
AN:
248856
Hom.:
AF XY:
AC XY:
1423
AN XY:
135200
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0136 AC: 19882AN: 1461730Hom.: 172 Cov.: 31 AF XY: 0.0133 AC XY: 9644AN XY: 727168
GnomAD4 exome
AF:
AC:
19882
AN:
1461730
Hom.:
Cov.:
31
AF XY:
AC XY:
9644
AN XY:
727168
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0101 AC: 1541AN: 152312Hom.: 11 Cov.: 32 AF XY: 0.00909 AC XY: 677AN XY: 74480
GnomAD4 genome
AF:
AC:
1541
AN:
152312
Hom.:
Cov.:
32
AF XY:
AC XY:
677
AN XY:
74480
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
7
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 29, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 09, 2024 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at